Literature DB >> 11385373

Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response.

S M Fiser1, C G Tribble, S M Long, A K Kaza, J T Cope, V E Laubach, J A Kern, I L Kron.   

Abstract

OBJECTIVE: Both donor pulmonary macrophages and recipient circulating leukocytes may be involved in reperfusion injury after lung transplantation. By using the macrophage inhibitor gadolinium chloride and leukocyte filters, we attempted to identify the roles of these two populations of cells in lung transplant reperfusion injury.
METHODS: With our isolated, ventilated, blood-perfused rabbit lung model, all groups underwent lung harvest followed by 18-hour cold storage and 2-hour blood reperfusion. Measurements of pulmonary artery pressure, lung compliance, and arterial oxygenation were obtained. Group I (n = 8) served as a control. Group II (n = 8) received gadolinium chloride at 14 mg/kg 24 hours before lung harvest. Group III (n = 8) received leukocyte-depleted blood reperfusion by means of a leukocyte filter.
RESULTS: The gadolinium chloride group had significantly improved arterial oxygenation and pulmonary artery pressure measurements compared with control subjects and an improved arterial oxygenation compared with the filter group after 30 minutes of reperfusion. After 120 minutes of reperfusion, however, the filter group had significantly improved arterial oxygenation and pulmonary artery pressure measurements compared with the control group and an improved arterial oxygenation compared with the gadolinium chloride group.
CONCLUSIONS: Lung transplant reperfusion injury occurs in two phases. The early phase is mediated by donor pulmonary macrophages and is followed by a late injury induced by recipient circulating leukocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11385373     DOI: 10.1067/mtc.2001.113603

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  46 in total

Review 1.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

2.  The influence of lung ischemia-reperfusion injury on myocardium.

Authors:  Meng Shi; Jiechun Huang; Liewen Pang; Xiaotian Sun; Xianglin Chu; Rongrong Jang; Xiaolin Xu; Yiqing Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury.

Authors:  Daniel P Mulloy; Ashish K Sharma; Lucas G Fernandez; Yunge Zhao; Christine L Lau; Irving L Kron; Victor E Laubach
Journal:  Ann Thorac Surg       Date:  2013-03-28       Impact factor: 4.330

Review 4.  Animal models of ex vivo lung perfusion as a platform for transplantation research.

Authors:  Kevin Nelson; Christopher Bobba; Samir Ghadiali; Don Hayes; Sylvester M Black; Bryan A Whitson
Journal:  World J Exp Med       Date:  2014-05-20

Review 5.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

6.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

7.  Chemokine Involvement in Lung Injury Secondary to Ischaemia/Reperfusion.

Authors:  Lisa Rancan; Sergio D Paredes; Luis Huerta; Javier Casanova; Jorge Guzmán; Ignacio Garutti; Federico González-Aragoneses; Carlos Simón; Elena Vara
Journal:  Lung       Date:  2017-04-21       Impact factor: 2.584

8.  Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.

Authors:  Ashish K Sharma; Victor E Laubach; Susan I Ramos; Yunge Zhao; George Stukenborg; Joel Linden; Irving L Kron; Zequan Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2009-11-11       Impact factor: 5.209

9.  Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study.

Authors:  Jing-hao Zheng; Bo-tao Gao; Zu-ming Jiang; Xiao-qing Yu; Zhi-wei Xu
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

10.  NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.

Authors:  Zequan Yang; Ashish K Sharma; Melissa Marshall; Irving L Kron; Victor E Laubach
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.